203 related articles for article (PubMed ID: 18579602)
1. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral.
Dimmock NJ; Rainsford EW; Scott PD; Marriott AC
J Virol; 2008 Sep; 82(17):8570-8. PubMed ID: 18579602
[TBL] [Abstract][Full Text] [Related]
2. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
Duhaut SD; Dimmock NJ
Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
[TBL] [Abstract][Full Text] [Related]
3. Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.
Noble S; Dimmock NJ
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3485-91. PubMed ID: 7996140
[TBL] [Abstract][Full Text] [Related]
4. Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease.
Duhaut SD; Dimmock NJ
J Virol Methods; 2003 Mar; 108(1):75-82. PubMed ID: 12565156
[TBL] [Abstract][Full Text] [Related]
5. In vivo antiviral activity: defective interfering virus protects better against virulent Influenza A virus than avirulent virus.
Dimmock NJ; Marriott AC
J Gen Virol; 2006 May; 87(Pt 5):1259-1265. PubMed ID: 16603528
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.
Dimmock NJ; Dove BK; Meng B; Scott PD; Taylor I; Cheung L; Hallis B; Marriott AC; Carroll MW; Easton AJ
Antiviral Res; 2012 Dec; 96(3):376-85. PubMed ID: 23041142
[TBL] [Abstract][Full Text] [Related]
7. A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral.
Smith CM; Scott PD; O'Callaghan C; Easton AJ; Dimmock NJ
Viruses; 2016 Aug; 8(8):. PubMed ID: 27556481
[TBL] [Abstract][Full Text] [Related]
8. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
9. Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza.
Zhao H; To KKW; Chu H; Ding Q; Zhao X; Li C; Shuai H; Yuan S; Zhou J; Kok KH; Jiang S; Yuen KY
Nat Commun; 2018 Jun; 9(1):2358. PubMed ID: 29907765
[TBL] [Abstract][Full Text] [Related]
10. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
11. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
12.
Sutton TC; Lamirande EW; Bock KW; Moore IN; Koudstaal W; Rehman M; Weverling GJ; Goudsmit J; Subbarao K
J Virol; 2017 Dec; 91(24):. PubMed ID: 29046448
[TBL] [Abstract][Full Text] [Related]
13. Activation of toll-like receptor signaling pathway for protection against influenza virus infection.
Wong JP; Christopher ME; Viswanathan S; Karpoff N; Dai X; Das D; Sun LQ; Wang M; Salazar AM
Vaccine; 2009 May; 27(25-26):3481-3. PubMed ID: 19200852
[TBL] [Abstract][Full Text] [Related]
14. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
15. A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.
Easton AJ; Scott PD; Edworthy NL; Meng B; Marriott AC; Dimmock NJ
Vaccine; 2011 Mar; 29(15):2777-84. PubMed ID: 21320545
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
17. Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.
Straight TM; Ottolini MG; Prince GA; Eichelberger MC
Virol J; 2008 Mar; 5():44. PubMed ID: 18355405
[TBL] [Abstract][Full Text] [Related]
18. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
Baz M; Paskel M; Matsuoka Y; Zengel JR; Cheng X; Treanor JJ; Jin H; Subbarao K
J Virol; 2015 Jul; 89(13):6907-17. PubMed ID: 25903333
[TBL] [Abstract][Full Text] [Related]
19. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
[TBL] [Abstract][Full Text] [Related]
20. Viral Factors Important for Efficient Replication of Influenza A Viruses in Cells of the Central Nervous System.
Siegers JY; van de Bildt MWG; Lin Z; Leijten LM; Lavrijssen RAM; Bestebroer T; Spronken MIJ; De Zeeuw CI; Gao Z; Schrauwen EJA; Kuiken T; van Riel D
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
